DEFINITIONS

“subsidiary(ies)”

has the meaning ascribed thereto in the Listing Rules

“substantial shareholder(s)”

has the meaning ascribed thereto in the Listing Rules

“Supervisor(s)”

the supervisor(s) of our Company

“Suzhou Benyu”

“Suzhou Junao”

“Suzhou Junmeng”

“Suzhou Junshi”

“Suzhou Ruiyuan”

Benyu

Tianyuan

Biological

Suzhou
Technology
Partnership (LP)* (蘇州本裕天源生物科技合夥企業(有限
合夥)) (previously known as Shenzhen Benyu Tianyuan
Biological Technology Partnership (LP)* (深圳本裕天源
生物科技有限合夥企業(有限合夥)), a limited partnership
established in the PRC on December 2, 2014, a
Shareholder and one of the Other Concert Parties

Suzhou Junao Precision Medicine Co., Ltd.* (蘇州君奧精
準醫學有限公司), a limited liability company established
in the PRC on January 10, 2018, and an indirect
wholly-owned subsidiary of our Company

Suzhou Junmeng Biosciences Co., Ltd.* (蘇州君盟生物
醫藥科技有限公司),
company
established in the PRC on October 12, 2013 and a direct
wholly-owned subsidiary of our Company

liability

limited

a

Suzhou Junshi Biosciences Co., Ltd.* (蘇州君實生物醫
藥科技有限公司), a limited liability company established
in the PRC on July 26, 2017 and a direct wholly-owned
subsidiary of our Company

Suzhou Ruiyuan
Shengben Biological Medicine
Management Partnership (LP)* (蘇州瑞源盛本生物醫藥
管理合夥企業(有限合夥)),
partnership
established in the PRC on July 11, 2013, a Shareholder
and one of the Other Concert Parties

limited

a

“Suzhou Union Biopharm”

“Taizhou Junshi”

Suzhou Union Biopharm Biosciences Co., Ltd.* (蘇州眾
合生物醫藥科技有限公司), a limited liability company
established in the PRC on October 12, 2013 and a direct
wholly-owned subsidiary of our Company

Taizhou Junshi Biosciences Co., Ltd.* (泰州君實生物醫
藥科技有限公司), a limited liability company established
in the PRC on May 9, 2014 and a direct wholly-owned
subsidiary of our Company

– 31 –

